The role of monoamine oxidase in the intraneuronal metabolism of norepinephrine released by indirectly-acting sympathomimetic amines or by adrenergic nerve stimulation.
D000818:Animals; D003042:Cocaine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D006325:Heart Atria / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D008616:Mephentermine / Q000494:pharmacology; D008750:Methyldopa / Q000494:pharmacology; D008995:Monoamine Oxidase / Q000494:pharmacology*; D009474:Neurons / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D010293:Pargyline / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000502:physiology*; D013566:Sympathomimetics / Q000494:pharmacology*; D014316:Tritium; D014439:Tyramine / Q000494:pharmacology; D014556:Urine
D013566:Sympathomimetics; D014316:Tritium; D008750:Methyldopa; D010293:Pargyline; D008995:Monoamine Oxidase; D003042:Cocaine; D008616:Mephentermine; D003913:Dextroamphetamine; D009638:Norepinephrine; D014439:Tyramine